Changchun GeneScience Pharmaceutical Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1948-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://english.ciac.cas.cn/
A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2024-01-12
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 86
- Registration Number
- NCT06204250
- Locations
- 🇦🇺
Linear Clinical Research, Perth, Western Australia, Australia
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
- First Posted Date
- 2024-01-03
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06189495
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳West China Hospital of Sichuan University, Chengdu, Sichuan, China
🇨🇳Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations
- Conditions
- Interventions
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06135168
- Locations
- 🇨🇳
Chengdu Xinhua Hospital affiliated to North Sichuan Medical College, Chengdu, Sichuan, China
A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations
- Conditions
- Interventions
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06135155
- Locations
- 🇨🇳
Chengdu Xinhua Hospital affiliated to North Sichuan Medical College, Chengdu, Sichuan, China
A Study for the Treatment of Dry Eye in Postmenopausal Women
- Conditions
- Interventions
- First Posted Date
- 2023-11-15
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT06133166
- Locations
- 🇨🇳
Xiamen Ophthalmology Center Affiliated to Xiamen University, Xiamen, Fujian, China
The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06095206
- Locations
- 🇨🇳
Chengdu Xinhua Hospital, affiliated with Sichuan North Medical College, Chengdu,, Sichuan, China
To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 176
- Registration Number
- NCT06091436
- Locations
- 🇨🇳
The Sixth Affiliated Hospital, Sun Yat-sen University Guangdong Gastrointestinal Hospital, Guangzhou, Guangdong, China
A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT06024967
A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 162
- Registration Number
- NCT06007417
- Locations
- 🇺🇸
Cook Childrens, Fort Worth, Texas, United States
Safety & Efffficacy of Genakumab in Patients With Frequent Flares
- Conditions
- Interventions
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 313
- Registration Number
- NCT05983445
- Locations
- 🇨🇳
Fudan University Affiliated Huashan Hospital, Shanghai, Shanghai, China